World’s first contact lens proven to slow the rate of myopic progression in children recognised at leading UK industry awards.
Southampton, United Kingdom, 8 May 2018 — Global contact lens manufacturer, CooperVision, is delighted to have won ‘Contact Lens Product of the Year’ for its MiSight® 1 day contact lens at the prestigious 2018 Optician Awards. Taking place at the Hilton Birmingham Metropole on Saturday 14th April, MiSight® 1 day took home the title thanks to its ability to make a real difference to the lives of patients and help grow the contact lens sector.
The coveted ‘Contact Lens Product of the Year’ award recognises the lens product that has made the biggest impact in offering new levels of performance, boosting new fit volumes or keeping patients in contact lenses. The judges selected MiSight® 1 day as the overall winner due to its level of innovation, success to date in practice and strong supporting marketing campaign.
With myopia reaching epidemic proportions, it is forecast by 2050 that 56% of the European population will be myopic[1]. Not just a visual inconvenience, myopia also increases the risk of associated pathologies such as myopic maculopathy and retinal detachment[2], both of which can lead to permanent visual loss and blindness.
MiSight® 1 day is the world’s first soft daily disposable contact lens proven to significantly slow the progression of myopia in children[3]* and therefore lower the risk of myopia-related ocular conditions later in life.
Collecting the award, CooperVision’s Head of Marketing and Professional Services for the UK & Ireland, Mark Draper, commented: “We’re thrilled to have won this award as it’s a real testament to CooperVision’s commitment to bringing to market truly innovative products that tackle some of the greatest challenges of our time.
“MiSight® 1 day is as easy to fit as a single-vision contact lens and doesn’t need any additional equipment, which makes the process simple for eye care professionals, whilst being easy for children to handle. Since launch, ECPs have embraced the opportunity to step up their clinical practice and we look forward to supporting them with further training and education in the coming months.”
For more details on MiSight® 1 day, visit www.coopervision.co.uk.
[1] Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036–1042.
[2] Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.
[3] Chamberlain P, Back A, Lazon P, et al. Three-year effectiveness of a dual-focus 1 day soft contact lens for myopia control. Presented at the 40th British Contact Lens Association Clinical Conference and Exhibition; 10 June 2017; Liverpool, United Kingdom.
*Compared with a standard single-vision, one-day lens over a three-year period.